Bogart Wealth’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
Bogart Wealth's IHE Position: Q3 2026 in Review
Bogart Wealth increased its iShares US Pharmaceuticals ETF (IHE) stake by 392% in Q3 2026, buying an estimated $20.5K and bringing the position to 251 shares worth $25.2K. The position accounts for ﹤0.01% of the portfolio, ranked #745.
Bogart Wealth first reported a position in IHE in Q4 2016 and has held it in 7 quarters since. The position peaked at $12.4M in Q4 2016. 245 funds tracked by Wall St. Rank hold IHE as of Q3 2026.
- Bogart Wealth held 251 shares of iShares US Pharmaceuticals ETF worth $25.2K as of Q3 2026.
- Bogart Wealth bought 200 iShares US Pharmaceuticals ETF shares in Q3 2026, an estimated $20.5K.
- iShares US Pharmaceuticals ETF made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #745 holding.
- Bogart Wealth first reported a position in iShares US Pharmaceuticals ETF in Q4 2016 and has held it in 7 quarters since.
- Bogart Wealth's iShares US Pharmaceuticals ETF position peaked at $12.4M in Q4 2016.
- 245 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.
Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.